Ashley Yeo

Ashley Yeo

Executive Editor, MTI; Medtech Editor, In Vivo

London, UK

Ashley has reported on health care market issues with Citleline and legacy companies since 1988, initially as a linguist on the France and Germany desk and later becoming editor of three titles. Two publications are his current focus for written and multimedia (panel moderating and podcasts) content: In Vivo (global medtech market access); and Medtech Insight (regulation and policy content for the UK, European and Asia markets).

Latest from Ashley Yeo

Midterm Swiss-EU Medtech MRA Still On Track After Bilaterals III

Renewal of the Swiss-EU Mutual Recognition Agreement for medical devices may still be a year or two away, but momentum towards ratification was maintained in March when Swiss and EU political leaders signed the final outstanding agreements of the Bilaterals III sectoral agreements.

EU’s Green Agenda Moves Back To Center Stage

Two lawyers within EU legal chamber Axon Lawyers created a Green Team to cope with the rise in EU Green Deal and related environmental sustainability and compliance needs for medtechs. One of them, Jilles van der Hoek, explains why manufacturers should be getting a jump on future requirements.

Practicalities For AI-Enabled Devices As Digital (R)evolution Picks Up Pace

AI-enabled tools deliver faster radiology reads, clinical decision-support, personalized treatment insights and continuous patient monitoring, but a new report from Firefinch Software and IMed Consultancy advises device developers how to enter and stay in this rapidly growing market.

Adapt To Survive: Private Hospitals In A High-Pressure Landscape

Payers' and patients' growing preference for outpatient care is increasing pressure on private providers to continually reassess how they deliver value. Jean-Philippe Grosmaitre and Guillaume Duparc, partners at L.E.K. Consulting, outlined growth opportunities available to private hospitals.

MDR/IVDR Changes And A Question of Balance: EU’s Várhelyi On Device Safety And Innovation

Certain short-term EU market improvement measures are expected to be in place this month, said the European Commission, which has challenged device industry stakeholders for input and advice as the EU’s late-2025 bundle of device regulatory improvements begins to take shape.

Highest WHO Acclaim For Singapore’s Regulation As IMDRF Profiles Global Playbook At 29th Meeting

IMDRF’s playbook on regulatory reliance was in the spotlight at the Forum’s 29th meeting this week, on the heels of its new midterm regulatory strategy document. 2026 IMDRF chair Singapore used the occasion to announce unprecedented WHO acclaim for the nation’s device regulatory oversight.